Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
NexGen Bio
Geumcheon-gu, Seoul, South Koreanexgenbiotech.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
NexGen Bio has multiple commercialized cosmeceutical products (including EGF-based lotions, creams, gels, and essence) and is a recognized innovator in recombinant protein engineering. It has developed rapid diagnostic kits (e.g., pregnancy tests), recombinant antigen proteins for infectious disease diagnostics, and received awards for protein production innovations, such as artificial spider venom protein manufacture.[1][2]
- Therapeutic areas
- DermatologyInfectious Diseases
- Modalities
- Recombinant proteinDiagnostic deviceCosmeceutical
- Industry
- Biotech
Beyond the preview
Go deeper on NexGen Bio.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on NexGen Bio.